Weekly insulin injection is here – are they any good?

11th June 2023, Dr Chee L Khoo

Weekly?

First, we have short acting GLP1-RA (exenatide) which requires twice a day injections. Then, we have once daily GLP1-RA injections (e.g. Exenatide ER, liraglutide, lixisenatide) which makes it more convenient for most patients. Of course, once daily injection is still too many. Once a week would be better, wouldn’t it? Of course, we now have weekly dulaglutide and semaglutide and patients love them.…

Diets for T2D – what should you tell your patient?

which diet?

10th June 2023, Dr Chee L Khoo

It’s all very confusing, isn’t it? Low fat, low carbohydrate, Mediterranean diet, Paleo diet, Nordic diet or DASH diet. There are many other diets which we haven’t even heard of. Are they any good? Do they cause harm? How can we advise our patients if we don’t know what those diets are?…

Knee MRI – the best investigation to elucidate the diagnosis

30th May, 2023, Spectrum Medical Imaging

Knee injuries are one of the most common injuries we see in general practice. We always start with history to determine the mechanism of injury. Examination is not always straight forward especially, if there is severe pain and restriction of movement. MRI is an excellent tool for demonstrating injuries of the internal soft tissue structures in the joints.…

Hypertriglyceridaemia – why is it not sexy to talk about it?

28th May 2023, Dr Chee L Khoo

Hypertriglyceridaemia has always played second fiddle to hypercholesterolaemia for a long time. Studies after studies have demonstrated the cardiovascular benefits of cholesterol lowering therapy. You might know that most of these clinical trials excluded patients with hypertriglyceridaemia. Does that mean that hypertriglyceridaemia doesn’t matter? We know hypertriglyceridaemia inflict oxidative damage to vital metabolic systems and organs.…

Danuglipron – the new, small kid on the GLP1-RA block

27th May 2023, Dr Chee L Khoo

small molecule agonist

The first GLP1- RA, exenatide was first isolated by John Eng in 1992 while working at the Veterans Administration Medical Center in the Bronx, New York.[1] It was made by Amylin Pharmaceuticals and commercialised by AstraZeneca. Exenatide was approved by the FDA on April 28, 2005, for people whose diabetes is not well controlled on other oral medications.…

CT Colonography vs Colonoscopy

NIA Diagnostic Imaging, 14th May 2023

Colorectal cancer (also known as bowel cancer) is the third most prevalent type of newly diagnosed cancer and the second deadliest type of cancer in Australia. CRC generally arises from the inner lining of the colon and is often characterised by polyps, which, if left undetected, can transform into aggressive malignancies. Despite the fact that optic colonoscopy is the golden standard for the detection of colorectal cancer, CT colonography (CTC) is regarded as a non-inferior alternative.…

TOBOGM has finally published – what has it taught us?

14th May 2023, Dr Chee L Khoo

TOBOGM is the very first study to see if immediate treatment of early gestational diabetes mellitus (GDM) increases or reduces pregnancy complications among women with GDM diagnosed with OGTT before 20 weeks’ gestation. TOBOGM study results will significantly contribute to the management decisions of pregnant women with early GDM. Campbelltown Hospital was the lead recruiting centre with Professor David Simmons being the chief investigator of this international study.…

Dementia and T2D – how are the related?

14th May 2023, Dr Chee L Khoo

When we think about diabetic complications, we usually think about microvascular and macrovascular complications. We don’t often think about dementia as a diabetic complication. Diabetes has consistently been associated with an increased risk of dementia and its subtypes (Alzheimer’s disease and vascular dementia (1). As many with diabetes, especially T2D, are being diagnosed at a younger age, dementia relating to diabetes will increasingly be diagnosed and diagnosed at a younger age.…

Morton’s Neuroma – A case study

30th April, Spectrum Medical Imaging

All medical students will remember Morton’s neuroma but they never tell us what to do after you suspect the foot symptoms are suggestive of Morton’s neuroma. It also known as inter-metatarsal neuroma. It is a focal area of perineural fibrosis around plantar digital nerves of the foot. It is thought to be due to chronic entrapment of the nerve by the inter-metatarsal ligament and can be a cause of metatarsalgia.…

Anti-platelet therapy with PCI – what do you need to know?

29th April 2023, Dr Chee L Khoo

anti-platelet therapy

We have a increasing number of patients who has undergone a percutaneous coronary intervention (PCI). This could be in the acute setting of an acute coronary syndrome (ACS) or electively during an exploratory angiogram. Stents used to be bare metal. Then came the first-generation drug eluting stents. The latest generation drug eluting stents are better at reducing subsequent thrombosis of the stented and unstented coronary segments.…

Neuropathic pain – what works and what doesn’t?

25th April 2023, Dr Chee L Khoo

We may not have many patients with neuropathic pain but patients with neuropathic pain can be heartsinks. Most of the time, nothing seems to work. It can be quite frustrating when anti-depressants after anti-depressants don’t work. The old tricyclics often don’t work either. What about pregabalin? Nope. What about gabapentin? Nope. What about long-acting opioids or tramadol?…

CT Coronary Angiogram – what is the prognostic value?

13th April 2023, NIA Diagnostic Imaging

CAD

A few months ago, we explored the role of coronary artery calcium score (CAC) as a cardiovascular risk assessment tool, and its importance in the prediction of future cardiovascular heart disease events and atherosclerotic cardiovascular disease (9). However, limited by the inability to assess the burden of non-calcified plaque which has low radiological attenuation, CT coronary angiography (CTCA) can be performed in conjunction with a CAC (6).…